Advanced Mapping and Ablation Procedures to Drive Growth in the Japanese Electrophysiology Market Over Coming Years
Recent technological advances in the treatment of heart arrhythmias have garnered significant interest and will drive electrophysiology (EP) device revenues in Japan throughout the coming years. According to a new report by Millennium Research Group, the Japanese market for EP mapping and ablation will grow by over $25 million throughout the next five years.
(PRWEB) November 7, 2004
Recent technological advances in the treatment of heart arrhythmias have garnered significant interest and will drive electrophysiology (EP) device revenues in Japan throughout the coming years. According to a new report by Millennium Research Group (MRG), the Japanese market for EP mapping and ablation will grow by over $25 million throughout the next five years, reaching annual sales of $125 million in 2009. In terms of procedures, over 24,000 electrophysiology studies (EPS) were performed in Japan in 2003. This number is forecast to increase to over 40,000 by 2009, driven to a large degree by the aging population.
The introduction and uptake of new, innovative EP mapping and ablation devices to the Japanese market will drive market revenues in the next five years. The availability of advanced EP devices in the Japanese market will provide the opportunity to detect and treat complex arrhythmias that are difficult to manage using conventional EP devices, and provide a safer and more effective standard of care for treating standard arrhythmias. In 2004, the Japanese catheter ablation (CA) market was valued at over $20 million. Improved CA devices, such as cryoablation and irrigated-tip catheters, are not yet available in Japan but will contribute to this growing market upon device approval. JapanÂ’s Ministry of Health, Labor, and Welfare is expected to approve 3-D advanced mapping systems for use in diagnosing arrhythmias during EPS. The approval of these advanced EP systems, in the next five years, will contribute to the growth of the Japanese EP market.
MRG's Japanese report is part of its Global Markets for the Electrophysiology Mapping and Ablation Market series, which includes analysis on the United States, Europe, and key industry competitors. The global report series covers over 20 competitors including St. Jude Medical (STJ), Biosense Webster (JNJ), Boston Scientific (BSX), Medtronic (MDT), C. R. Bard (BCR), GE Healthcare (GE), EP Medsystems (EPMD), Cardima (CRDM), and CryoCath Technologies (CYT–TSX).
A leading source of competitive intelligence, MRG is now the largest provider of medical device market research in the world. Located in Toronto, Canada, MRG covers global markets and has pioneered reporting of numerous emerging products.
Contact Information:
Canossa Chan
Millennium Research Group Inc.
(416) 364-7776 ext.129
Www. mrg. net
###
